Gestational toluene exposure effects on spontaneous and amphetamine-induced locomotor behavior in rats

Neurotoxicology and Teratology

Volumn 29, Issue 2, 2007, Pages 236-246

  Bowen, Scott E ^a,b   Mohammadi, Michael H ^a,b   Batis, Jeffery C ^a,b   Hannigan, John H ^a,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activity; Gestational toluene exposure; Rats; Toluene

Indexed keywords

AMPHETAMINE; TOLUENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EXPERIMENTAL STUDY; FEMALE; GESTATION PERIOD; INHALANT ABUSE; LOCOMOTION; MALE; MEASUREMENT; MOTOR ACTIVITY; NONHUMAN; PERINATAL PERIOD; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT;

AGE FACTORS; AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; MALE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TOLUENE;

RATTUS;

EID: 33947162594     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2006.09.027     Document Type: Article

References (53)

1. Arnold G.L., Kirby R.S., Langendoerfer S., and Wilkins-Haug L. Toluene embryopathy: clinical delineation and developmental follow-up. Pediatrics 93 (1994) 216-220
2. Bale A.S., Meacham C.A., Benignus V.A., Bushnell P.J., and Shafer T.J. Volatile organic compounds inhibit human and rat neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. Toxicol. Appl. Pharmacol. 205 (2005) 77-88
3. Bale A.S., Tu Y., Carpenter-Hyland E.P., Chandler L.J., and Woodward J.J. Alterations in glutamatergic and GABAergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience 130 (2005) 197-206
4. Balster R.L. Neural basis of inhalant abuse. Drug Alcohol Depend. 51 (1998) 207-214
5. Beauvais F., Wayman J.C., Jumper-Thurman P., Plested B., and Helm H. Inhalant abuse among American Indian, Mexican American, and non-Latino white adolescents. Am. J. Drug Alcohol Abuse 28 (2002) 171-187
6. Beckstead M.J., Weiner J.L., Eger II E.I., Gong D.H., and Mihic S.J. Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol. Pharmacol. 57 (2000) 1199-1205
7. Bowen S.E., and Hannigan J.H. Developmental toxicity of prenatal exposure to toluene. AAPS J. 8 (2006) E419-E424. http://www.aapsj.org. (http://www.aapsj.org.)
8. Bowen S.E., Batis J.C., Mohammadi M., and Hannigan J.H. Abuse patterns of gestational toluene exposure and early postnatal development in rats. Neurotoxicol. Teratol. 27 (2005) 105-116
9. Brouette T., and Anton R. Clinical review of inhalants. Am. J. Addict. 10 (2001) 79-94
10. Bukowski J.A. Review of epidemiological evidence relating toluene to reproductive outcomes. Regul. Toxicol. Pharmacol. 33 (2001) 147-156
11. Coleman C.N., Mason T., Hooker E.P., and Robinson S.E. Developmental effects of intermittent prenatal exposure to 1,1,1-trichloroethane in the rat. Neurotoxicol. Teratol. 21 (1999) 699-708
12. Cruz S.L., Mirshahi T., Thomas B., Balster R.L., and Woodward J.J. Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 286 (1998) 334-340
13. Elfenbein D.S., and Felice M.E. Adolescent pregnancy. Pediatr. Clin. North Am. 50 (2003) 781-800
14. Fornazzari L. The neurotoxicity of inhaled toluene. Can. J. Psychiatry 35 (1990) 723
15. Fornazzari L., Riley D., Wu P., and Carlen P.L. Toluene abuse and neurologic impairment. Neurology 37 (1987) 356
16. Fornazzari L., Wilkinson D.A., Kapur B.M., and Carlen P.L. Cerebellar, cortical and functional impairment in toluene abusers. Acta. Neurol. Scand. 67 (1983) 319-329
17. Gerasimov M.R., Schiffer W.K., Marstellar D., Ferrieri R., Alexoff D., and Dewey S.L. Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend. 65 (2002) 243-251
18. Goodwin T.M. Toluene abuse and renal tubular acidosis in pregnancy. Obstet. Gynecol. 71 (1988) 715-718
19. Hass U., Lund S.P., Hougaard K.S., and Simonsen L. Developmental neurotoxicity after toluene inhalation exposure in rats. Neurotoxicol. Teratol. 21 (1999) 349-357
20. Hersh J.H. Toluene embryopathy: two new cases. J. Med. Genet. 26 (1989) 333-337
21. Hersh J.H., Podruch P.E., Rogers G., and Weisskopf B. Toluene embryopathy. J. Pediatr. 106 (1985) 922-927
22. Hougaard K.S., Hass U., Lund S.P., and Simonsen L. Effects of prenatal exposure to toluene on postnatal development and behavior in rats. Neurotoxicol. Teratol. 21 (1999) 241-250
23. Hougaard K.S., Andersen M.B., Hansen HA.M., Hass U., Werge T., and Lund S.P. Effects of prenatal exposure to chronic mild stress and toluene in rats. Neurotoxicol. Teratol. 27 (2005) 153-167
24. Hunter A.G., Thompson D., and Evans J.A. Is there a fetal gasoline syndrome?. Teratology 20 (1979) 75-79
25. L.D. Johnston, P.M. O'Malley, J.G. Bachman, Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2002. (2003; NIH Publication No. 03-5374). Bethesda, MD, National Institute on Drug Abuse.
26. Jones H.E., and Balster R.L. Neurobehavioral consequences of intermittent prenatal exposure to high concentrations of toluene. Neurotoxicol. Teratol. 19 (1997) 305-313
27. Jones H.E., and Balster R.L. Inhalant abuse in pregnancy. Obst. Gynecol. Clin. North Am. 25 (1998) 153-167
28. Jones H.E., Kunko P.M., Robinson S.E., and Balster R.L. Developmental consequences of intermittent and continuous prenatal exposure to 1,1,1-trichloroethane in mice. Pharmacol. Biochem. Behav. 55 (1996) 635-646
29. Kamran S., and Bakshi R. MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology 40 (1998) 519-521
30. Kurtzman T.L., Otsuka K.N., and Wahl R.A. Inhalant abuse by adolescents. J. Adolesc. Health 28 (2001) 170-180
31. Lazar R.B., Ho S.U., Melen O., and Daghestani A.N. Multifocal central nervous system damage caused by toluene abuse. Neurology 33 (1983) 1337-1340
32. Lopreato G.F., Phelan R., Borghese C.M., Beckstead M.J., and Mihic S.J. Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend. 70 (2003) 11-15
33. Malm G., and Lying-Tunell U. Cerebellar dysfunction related to toluene sniffing. Acta. Neurol. Scand. 62 (1980) 188-190
34. McGarvey E.L., Clavet G.J., Mason W., and Waite D. Adolescent inhalant abuse: environments of use. Am. J. Drug Alcohol Abuse 25 (1999) 731-741
35. Ng T.P., Foo S.C., and Yoong T. Risk of spontaneous abortion in workers exposed to toluene. Br. J. Ind. Med. 49 (1992) 804-808
36. Noda S., Yamanouchi N., Okada S., Kodama K., Murakami A., Sekine H., Sakamoto T., Komatsu N., Sato T., Ikehira H., and Morita F. Proton MR spectroscopy in solvent abusers. Ann. N. Y. Acad. Sci. 801 (1996) 441-444
37. Oetting E.R., Edwards R.W., and Beauvais F. Social and psychological factors underlying inhalant abuse. NIDA Res. Monogr. 85 (1988) 172-203
38. Okada S., Yamanouchi N., Kodama K., Uchida Y., Hirai S., Sakamoto T., Noda S., Komatsu N., and Sato T. Regional cerebral blood flow abnormalities in chronic solvent abusers. Psychiatry Clin. Neurosci. 53 (1999) 351-356
39. Pearson M.A., Hoyme H.E., Seaver L.H., and Rimsza M.E. Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 93 (1994) 211-215
40. Rosenberg N.L., Kleinschmidt-DeMasters B.K., Davis K.A., Dreisbach J.N., Hormes J.T., and Filley C.M. Toluene abuse causes diffuse central nervous system white matter changes. Ann. Neurol. 23 (1988) 611-614
41. Sharp C.W., and Rosenberg R.N. Inhalants. In: Lowinson J.H., Ruiz P., Millman R.B., and Langrod J.G. (Eds). Substance Abuse: A Comprehensive Textbook. 3rd ed (1996), Williams and Wilkins 246-264
42. Smart R.G. The epidemiology of volatile solvent/inhalant use in North America. In: Arif A., Grant M., and Navaratnam V. (Eds). Abuse of Volatile Solvents and Inhalants: Papers Presented at a W.H.O. Advisory Meeting, Penang, Malaysia: W.H.O Training Center, Universiti Sains Malaysia (1988) 172-203
43. Substance Abuse and Mental Health Services Administration. Substance Abuse and Mental Health Services Administration. Results from the 2002 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NHSDA Series H-22, DHHS Publication No. SMA 033836). Rockville, MD. (2003).
44. Takebayashi K., Sekine Y., Takei N., Minabe Y., Isoda H., Takeda H., Nishimura K., Nakamura K., Suzuki K., Iwata Y., Sakahara H., and Mori N. Metabolite alterations in basal ganglia associated with psychiatric symptoms of abstinent toluene users: a proton MRS study. Neuropsychopharmacology 29 (2004) 1019-1026
45. Thiel R., and Chahoud I. Postnatal development and behaviour of Wistar rats after prenatal toluene exposure. Arch. Toxicol. 71 (1997) 258-265
46. Toutant C., and Lippmann S. Fetal solvents syndrome. Lancet 1 (1979) 1356
47. Uchino A., Kato A., Yuzuriha T., Takashima Y., Hiejima S., Murakami M., Endoh K., Yoshikai T., and Kudo S. Comparison between patient characteristics and cranial MR findings in chronic thinner intoxication. Eur. Radiol. 12 (2002) 1338-1341
48. Yamanouchi N., Okada S., Kodama K., Hirai S., Sekine H., Murakami A., Komatsu N., Sakamoto T., and Sato T. White matter changes caused by chronic solvent abuse. Am. J. Neuroradiol. 16 (1995) 1643-1649
49. Yamanouchi N., Okada S., Kodama K., Sakamoto T., Sekine H., Hirai S., Murakami A., Komatsu N., and Sato T. Effects of MRI abnormalities on WAIS-R performance in solvent abusers. Acta Neurol. Scand. 96 (1997) 34-39
50. Yamawaki S., Segawa T., and Sarai K. Effects of acute and chronic toluene inhalation on behavior and (3H)-serotonin binding in rat. Life Sci. 30 (1982) 1997-2002
51. Wilkins-Haug L., and Gabow P.A. Toluene abuse during pregnancy: obstetric complications and perinatal outcomes. Obstet. Gynecol. 77 (1991) 504-509
52. Wu L., Schlenger W.E., and Ringwalt C.L. Use of nitrite inhalants ("poppers") among American youth. J. Adolesc. Health 37 (2005) 52-60
53. van Asperen J., Rijcken W.R., and Lammers J.H. Application of physiologically based toxicokinetic modelling to study the impact of the exposure scenario on the toxicokinetics and the behavioural effects of toluene in rats. Toxicol. Lett. 138 (2003) 51-62